Search Within

Urvi A Shah

Formats
  1. Meeting Abstract (136)
  2. Journal Article (38)
  3. Research Letter (12)
  4. Review (10)
  5. Correspondence (4)
  6. Editorial (2)
  7. Book Section (1)
Groups
  1. CTCR Scholars (203)
  2. Department of Medicine (203)
  3. Hematologic Malignancies, Division of (203)
  4. Center for Hematologic Malignancies (156)
  5. Myeloma (155)
  6. Hematologic Malignancies Research (150)

More Groups

People
  1. Alexander Lesokhin (146)
  2. Sham Mailankody (141)
  3. Malin Hultcrantz (135)
  4. Neha Korde (133)
  5. Hani Hassoun (132)
  6. Carlyn Rose Tan (122)

More People

Years
  1. 2025 (10)
  2. 2024 (49)
  3. 2023 (44)
  4. 2022 (44)
  5. 2021 (16)
  6. 2020 (20)

More Years

Publications
  1. Blood (76)
  2. Clinical Lymphoma, Myeloma and Leukemia (42)
  3. Journal of Clinical Oncology (15)
  4. Blood Cancer Journal (9)
  5. Blood Advances (8)
  6. Biology of Blood and Marrow Transplantation (4)

More Publications

Publishers
  1. American Society of Hematology (84)
  2. Elsevier Inc. (52)
  3. American Society of Clinical Oncology (15)
  4. Nature Publishing Group (14)
  5. American Association for Cancer Research (6)
  6. American Medical Association (4)

More Publishers

Results (203)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • African American patients with smoldering multiple myeloma may have a lower risk of progression compared to White patients
    Meeting Abstract

    Akhlaghi, T.; Maclachlan, K.; Korde, N.; Mailankody, S.; Lesokhin, A. M.; Hassoun, H.; Lu, S. X.; Patel, D.; Shah, U. A.; Tan, C.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Evaluating serum-free light chain ratio as a biomarker for multiple myeloma
    Meeting Abstract

    Akhlaghi, T.; Maclachlan, K.; Korde, N.; Mailankody, S.; Lesokhin, A. M.; Hassoun, H.; Lu, S. X.; Patel, D.; Shah, U. A.; Tan, C.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Ixazomib and dexamethasone in high risk smoldering multiple myeloma: A clinical and correlative pilot study
    Correspondence

    Mailankody, S.; Salcedo, M.; Tavitian, E.; Burge, M.; Korde, N.; Hassoun, H.; Lesokhin, A.; Lahoud, O.; Smith, E.; Hultcrantz, M.; more...
    Leukemia and Lymphoma (2022)

    Fulltext@MSK | Save
  • Dupilumab for the treatment of refractory lenalidomide rash in patients with multiple myeloma
    Research Letter

    Kuo, A. M.; Hassoun, H.; Shah, U.; Gordon, A.; Hollmann, T. J.; Landau, H. J.; Lezcano, C.; Mailankody, S.; Tan, C. C.; Lesokhin, A. M.; more...
    Leukemia and Lymphoma (2022)

    Fulltext@MSK | Save
  • GPRC5D-targeted CAR T cells for myeloma
    Journal Article

    Mailankody, S.; Devlin, S. M.; Landa, J.; Nath, K.; Diamonte, C.; Carstens, E. J.; Russo, D.; Auclair, R.; Fitzgerald, L.; Cadzin, B.; more...
    New England Journal of Medicine (2022)

    Fulltext@MSK | Save
  • Plant-based and ketogenic diets as diverging paths to address cancer: A review
    Review

    Shah, U. A.; Iyengar, N. M.
    JAMA Oncology (2022)

    Fulltext@MSK | Save
  • Myeloma precursor disease (MGUS) among rescue and recovery workers exposed to the World Trade Center disaster
    Journal Article

    Zeig-Owens, R.; Goldfarb, D. G.; Luft, B. J.; Yang, X.; Murata, K.; Ramanathan, L.; Thoren, K.; Doddi, S.; Shah, U. A.; Mueller, A. K.; more...
    Blood Cancer Journal (2022)

    Fulltext@MSK | Save
  • Interim analysis of the 2nd chance protocol: A multicenter trial of daratumumab, carfilzomib, lenalidomide, & dexamethasone for relapsed/refractory myeloma with salvage autologous hematopoietic cell transplantation
    Meeting Abstract

    Shah, G. L.; Bal, S.; Rodriguez, C.; Chhabra, S.; Bayer, R. L.; Costa, L. J.; Lambird, J.; Ferrer, C.; Parascondola, A.; Marcello, L.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Allogeneic stem cell transplantation improves survival in North American adult T-cell leukemia and lymphoma (NA-ATLL) with CNS involvement with minimal graft versus host disease (GVHD)
    Meeting Abstract

    Patel, R.; Shah, N.; Thakkar, A.; Rahman, S.; Acuna-Villaorduna, A.; Shah, U. A.; Herrera, D. A.; Slasky, S.; Gritsman, K.; Goldfinger, M.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Evaluation of potential predictors of central nervous system (CNS) involvement in North American adult T-cell leukemia lymphoma (ATLL) and their survival pattern
    Meeting Abstract

    Patel, R.; Shah, N.; Thakkar, A.; Rahman, S.; Acuna-Villaorduna, A.; Shah, U. A.; Herrera, D. A.; Slasky, S.; Gritsman, K.; Goldfinger, M.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save